<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04361201</url>
  </required_header>
  <id_info>
    <org_study_id>APHP200788</org_study_id>
    <secondary_id>2020-A01317-32</secondary_id>
    <nct_id>NCT04361201</nct_id>
  </id_info>
  <brief_title>Analysis of the Ligamentization Process in the Anatomical Ligamentoplasty of the Lateral Ankle Plane to the Hamstrings</brief_title>
  <acronym>LIGANALYS</acronym>
  <official_title>Analysis of the Ligamentization Process in the Anatomical Ligamentoplasty of the Lateral Ankle Plane to the Hamstrings</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective bi-centric study, which evaluate the evolution of RMI signal of&#xD;
      transplant till 12 months after ligament plasty surgery.&#xD;
&#xD;
      As the primary objective, the study aims to define the post-operative timeframe needed to&#xD;
      obtain an optimal quality of repair, especially in their restarting of sportive activities,&#xD;
      by analysis of RMI signal and biomechanic features modifications.&#xD;
&#xD;
      As secondary objectives, the study aims to:&#xD;
&#xD;
        -  study the correlation between the RMI signal of plasty and the Young's modulus;&#xD;
&#xD;
        -  study the evolution of RMI of plasty at M3, M6 and M12;&#xD;
&#xD;
        -  study the evolution of Young's modulus at M3, M6 and M12;&#xD;
&#xD;
        -  evaluate the reproductibility between 2 lector of RMI measurements;&#xD;
&#xD;
        -  evaluate the reproductibility between 2 lector of elastography measurements of LTFA;&#xD;
&#xD;
        -  evaluate the optimal delay of return to sport after ligament plasty surgery of ankle;&#xD;
&#xD;
        -  develope a score of type SNQ for ankle ligament plasty surgery;&#xD;
&#xD;
        -  evolution of AOFAS and EVA scores.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The eligible patients will be enrolled in the department of orthopaedic surgery of Ambroise&#xD;
      Paré hospital, each patient will undergo a 12-months follow-up in the department of&#xD;
      orthopaedic surgery in Armand Trousseau hospital for the elastography evaluations.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Classification of RMI signal</measure>
    <time_frame>At 3 months</time_frame>
    <description>The classification of RMI signal will be defined as:&#xD;
frank hyposignal: stage 1;&#xD;
intermediary signal (close to muscles of T2): stage 2;&#xD;
moderate hypersignal (close to cartilage of T2): stage 3;&#xD;
intensive hypersignal (close tointra-articular liquid of T2): stage 4.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Classification of RMI signal</measure>
    <time_frame>At 6 months</time_frame>
    <description>The classification of RMI signal will be defined as:&#xD;
frank hyposignal: stage 1;&#xD;
intermediary signal (close to muscles of T2): stage 2;&#xD;
moderate hypersignal (close to cartilage of T2): stage 3;&#xD;
intensive hypersignal (close tointra-articular liquid of T2): stage 4.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Classification of RMI signal</measure>
    <time_frame>At 12 months</time_frame>
    <description>The classification of RMI signal will be defined as:&#xD;
frank hyposignal: stage 1;&#xD;
intermediary signal (close to muscles of T2): stage 2;&#xD;
moderate hypersignal (close to cartilage of T2): stage 3;&#xD;
intensive hypersignal (close tointra-articular liquid of T2): stage 4.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anterior talofibular ligament measurement</measure>
    <time_frame>At 3, 6 and 12 months</time_frame>
    <description>anterior talofibular ligament measurement will be performed by RMI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Calcaneofibular ligament measurement</measure>
    <time_frame>At 3, 6 and 12 months</time_frame>
    <description>calcaneofibular ligament measurement will be performed by RMI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Elastography</measure>
    <time_frame>At 3, 6 and 12 months</time_frame>
    <description>Elastography measurements: Young's Modulu</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain evaluation</measure>
    <time_frame>At baseline and 3, 6 and 12 months</time_frame>
    <description>By the American Orthopedic Foot and Ankle Score (AOFAS) to evaluate the pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain evaluation</measure>
    <time_frame>At baseline and 3, 6 and 12 months</time_frame>
    <description>By the visual analog scale (VAS) to evaluate the pain.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Ligament Plastic Surgery</condition>
  <arm_group>
    <arm_group_label>Ligament plastic surgery ankle</arm_group_label>
    <description>Patient treated priorly by ligament plastic surgery of lateral ankle plane under arthroscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Controlateral ankle</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ligament plastic surgery</intervention_name>
    <description>Ligament plastic surgery of ankle under arthroscopy for recurrent instable ankle reason and failure of medical treatment.</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Ligament plastic surgery ankle</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>RMI and ultrasound</intervention_name>
    <description>RMI examination at 3 months on operated ankle, and 3 CT scan examinations with elastography module will be performed at planned timeframes.</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Ligament plastic surgery ankle</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients underwent a ligament plastic surgery of lateral ankle plane under arthroscopy.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient treated priorly by ligament plastic surgery of lateral ankle plane under&#xD;
             arthroscopy;&#xD;
&#xD;
          -  Affiliated to or covered by the French social security - welfare system in France;&#xD;
&#xD;
          -  Have provided written informed consent for the study;&#xD;
&#xD;
          -  Be &gt;/= 18 years of age on day of signing informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who undergo iterative surgery or have history of contralateral surgery;&#xD;
&#xD;
          -  Patient under guardianship or curatorship;&#xD;
&#xD;
          -  Unable to understand the proposed study or provide written informed consent for the&#xD;
             study;&#xD;
&#xD;
          -  Foreign patients under AME schema, a medical help from the state in France;&#xD;
&#xD;
          -  Pregnant or breastfeeding woman;&#xD;
&#xD;
          -  Patient refusal.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandre HARDY, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orthopaedic Surgery Department, Ambroise Paré hospital, APHP</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas BAUER, MD</last_name>
    <role>Study Director</role>
    <affiliation>Orthopaedic Surgery Department, Ambroise Paré hospital, APHP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexandre HARDY, MD</last_name>
    <phone>0615101016</phone>
    <email>alexandre.hardy@me.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thomas BAUER, MD</last_name>
    <phone>+33 (0)149095000</phone>
    <email>thomas.bauer@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Orthopaedic Surgery Department, Ambroise Paré hospital, APHP</name>
      <address>
        <city>Boulogne-Billancourt</city>
        <zip>92100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 20, 2020</study_first_submitted>
  <study_first_submitted_qc>April 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2020</study_first_posted>
  <last_update_submitted>September 22, 2021</last_update_submitted>
  <last_update_submitted_qc>September 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ligament injury</keyword>
  <keyword>ligamentization</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

